MIRA
HealthcareMIRA Pharmaceuticals, Inc.
$1.49
+$0.00 (+0.00%)
Jan 5, 2026
Price History (1Y)
Analysis
MIRA Pharmaceuticals, Inc. is a healthcare company operating in the drug manufacturers - general industry. The company's market capitalization is $62.40 million, indicating its relatively small scale within the sector. Financially, MIRA has reported significant losses, with a net income of -$28,415,680 over the trailing twelve months. The company's margins are all zero percent, suggesting that it has not yet achieved profitability. In terms of returns, MIRA's return on equity is -123.3%, and its return on assets is -74.6%. The company holds a significant amount of cash, with $7.54 million in liquid assets. Valuation metrics indicate a price to book ratio of 7.80, suggesting that the company's stock price may be relatively high compared to its book value. However, the forward P/E ratio and EV/EBITDA are not available for comparison. The company does not pay dividends, with a payout ratio of 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Visit website →Key Statistics
- Market Cap
- $62.40M
- P/E Ratio
- N/A
- 52-Week High
- $2.45
- 52-Week Low
- $0.73
- Avg Volume
- 3.09M
- Beta
- 1.81
Company Info
- Industry
- Drug Manufacturers - General
- Exchange
- NCM
- Country
- United States